Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Long-Term Incidence of A-Fib Increased in Women With Breast Cancer
THURSDAY, Jan. 31, 2019 (HealthDay News) — Women with breast cancer have an increased long-term incidence of atrial fibrillation (AF), according to a study published online Jan. 28 in Heart Rhythm.
Symptom Combos Suggesting Laryngeal Cancer Identified
THURSDAY, Jan. 31, 2019 (HealthDay News) — New symptom combinations that may indicate early symptoms of laryngeal cancer have been identified, according to a study published online Jan. 28 in the British Journal of General Practice.
E-Cigarettes More Effective for Smoking Cessation
THURSDAY, Jan. 31, 2019 (HealthDay News) — Electronic cigarettes are more effective for smoking cessation than nicotine replacement therapy, according to a study published online Jan. 30 in the New England Journal of Medicine.
FDA Receives an ‘F’ in Tobacco Prevention Report Card
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The U.S. Food and Drug Administration was given an “F” in a new American Lung Association report card evaluating tobacco prevention programs.
9/11 Responders May Have Higher Head, Neck Cancer Risk
TUESDAY, Jan. 29, 2019 (HealthDay News) — There may be a significant, emerging risk for human papillomavirus (HPV)-related head and neck cancers (HNC) among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC), according to a study recently published in the International Journal of Cancer.
Finasteride Not Tied to Increase in Prostate Cancer Mortality
TUESDAY, Jan. 29, 2019 (HealthDay News) — Finasteride is not associated with an increased risk for death due to prostate cancer, according to a research letter published in the Jan. 24 issue of the New England Journal of Medicine.
Tachycardia May Indicate Higher Mortality Risk in Cancer Patients
MONDAY, Jan. 28, 2019 (HealthDay News) — For patients with cancer, tachycardia can predict the risk for mortality, according to a study presented at the Advancing the Cardiovascular Care of the Oncology Patient conference organized by the American College of Cardiology and held from Jan. 25 to 27 in Washington, D.C.
Direct-Acting Antivirals Not Tied to Liver Cancer Recurrence